Portfolio of Coronavirus Treatment and Vaccine Stocks
The following table includes 18 coronavirus treatment and vaccine stocks. For more information about these stocks see These 19 companies are working on coronavirus treatments or vaccines — here’s where things stand.
| 18 Coronavirus Treatment and Vaccine Stocks | ||
|---|---|---|
Name | Symbol | Recent Prices |
| AstraZeneca | AZN | |
| BioNTech | BNTX | |
| CytoDyn | CYDY | |
| Emergent BioSolutions | EBS | |
| Gilead Sciences | GILD | |
| GlaxoSmithKline | GSK | |
| Inovio Pharmaceuticals | INO | |
| Johnson & Johnson | JNJ | |
| Mesoblast Limited | MESO | |
| Moderna | MRNA | |
| Novavax | NVAX | |
| Pfizer | PFE | |
| Regeneron Pharmaceuticals | REGN | |
| Roche Holding | RHHBY | |
| Sanofi | SNY | |
| Takeda Pharmaceutical Company Ltd. | TAK | |
| Translate Bio | TBIO | |
| Vir Biotechnology | VIR | |
| Sparkline weekly price charts based on Alpha Vantage data. | ||
Portfolio Values
To inspect the performance of the Coronavirus Treatment and Vaccine Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 13 stocks included in the portfolio computations are: AZN, CYDY, EBS, GILD, GSK, INO, JNJ, NVAX, PFE, REGN, RHHBY, SNY and TAK. The current value of the portfolio assumes that $769.23 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 5 stocks excluded from the portfolio computations because of insufficient price data are: BNTX, MESO, MRNA, TBIO and VIR.The current value of the $10,000 investment is $12,875. The percent return is 28.75%. The annualized return is 5.18%.
| 13 Coronavirus Treatment and Vaccine Stocks Returns | ||
|---|---|---|
Name | Symbol | % Return & Details |
| AstraZeneca | AZN | 130.37% |
| CytoDyn | CYDY | -45.75% |
| Emergent BioSolutions | EBS | -9.97% |
| Gilead Sciences | GILD | 6.72% |
| GlaxoSmithKline | GSK | 31.76% |
| Inovio Pharmaceuticals | INO | -77.17% |
| Johnson & Johnson | JNJ | 52.62% |
| Novavax | NVAX | 125.43% |
| Pfizer | PFE | 92.28% |
| Regeneron Pharmaceuticals | REGN | 21.68% |
| Roche Holding | RHHBY | 48.55% |
| Sanofi | SNY | 34.58% |
| Takeda Pharmaceutical Company Ltd. | TAK | -37.32% |
Portfolio Value Chart for Last 100 Daily Closes
See Portfolio of Coronavirus Stocks.
See Portfolio of Coronavirus Lockdown Stocks.
See Portfolio of Coronavirus Vaccine Stocks.
Related Portfolios
Portfolio of Medical Device Maker Stocks
Portfolio of Medical Diagnostic Stocks
Portfolio of Medical Equipment Stocks
Portfolio of Medical Instruments and Supplies Stocks
Portfolio of Medical Laboratory and Research Stocks